ALB Shorts Stay Elevated but Cheap Ahead of Wednesday's Print
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Albemarle, the world's largest lithium producer, reports third-quarter results on Wednesday against a backdrop of a stock that has lost 15% over the past month and now trades at $91.00, less than 60% of the consensus analyst price target.
Short positioning is the clearest pre-earnings signal. SI climbed 5.9% in a single week to 10.3% of the free float, a level confirmed by the FINRA fortnightly count of 12.25 million shares with 4.95 days to cover. That is the highest reading in roughly six weeks, and the rebuild has been consistent throughout October from a base near 10.1 million shares in mid-September. Yet the borrow market is not under stress. Availability is running at 509%, meaning roughly five shares remain in the lending pool for every one already borrowed, well above the 52-week tightest point of 305%. Borrowing costs are just 0.48%. New shorts are cheap and easy to establish, which makes the continued build a deliberate choice rather than a mechanical one.
Options positioning pulls in the opposite direction. The put/call ratio has eased to 0.89, more than a standard deviation below its 20-day average, and sits near the lower end of the 52-week range. After spending most of October above 1.0, a level that implied heavy demand for downside protection, the ratio has unwound sharply over the past two weeks. That rotation toward calls ahead of the print suggests some investors are positioning for a positive surprise rather than an extension of the selloff.
The analyst community has spent October trimming targets without abandoning positive ratings. Citigroup cut its target from $175 to $125 on October 22 while keeping a Buy. RBC lowered from $157 to $129, also maintaining Outperform. Targets across the coverage group now cluster in the $125 to $185 range against a stock at $91, so the implied upside is substantial even after the round of reductions. The debate is a familiar one for lithium names: bulls point to Albemarle's integrated low-cost asset base, net leverage of just 0.5x, $3.2 billion of liquidity, and management's argument that channel inventories are thin enough to tighten pricing. Bears see a business structurally exposed to lithium spot prices that have not recovered, with geopolitical risk in Chile and the possibility that slower EV adoption pushes the tightening cycle further out. At a trailing P/E of 8.6x and EV/EBITDA of 5.7x, the stock is pricing in a prolonged weak-price environment.
The prior two earnings prints resulted in gains of roughly 4% and 10% on the day, so the market has rewarded results before. Wednesday's report will test whether the rebound in forward earnings expectations, which rank in the 97th percentile of the ORTEX universe for year-on-year improvement, reflects a genuine turn in lithium market conditions or simply the arithmetic of a depressed 2025 earnings base.
Stocks in this article
See the live data behind this article on ORTEX.
Open ALB on ORTEX →How this article was generated
- Generated
- 1 Nov 2026, 04:06
- Data as of
- 1 Nov 2026, 04:00
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
- Validation notes
- soft: missing section mentions: short interest (informational only)
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.